185 related articles for article (PubMed ID: 15377319)
1. A double-blind study of SB-220453 (Tonerbasat) in the glyceryltrinitrate (GTN) model of migraine.
Tvedskov JF; Iversen HK; Olesen J
Cephalalgia; 2004 Oct; 24(10):875-82. PubMed ID: 15377319
[TBL] [Abstract][Full Text] [Related]
2. The prophylactic effect of valproate on glyceryltrinitrate induced migraine.
Tvedskov JF; Thomsen LL; Iversen HK; Gibson A; Wiliams P; Olesen J
Cephalalgia; 2004 Jul; 24(7):576-85. PubMed ID: 15196300
[TBL] [Abstract][Full Text] [Related]
3. The effect of propranolol on glyceryltrinitrate-induced headache and arterial response.
Tvedskov JF; Thomsen LL; Thomsen LL; Iversen HK; Williams P; Gibson A; Jenkins K; Peck R; Olesen J
Cephalalgia; 2004 Dec; 24(12):1076-87. PubMed ID: 15566422
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis.
Goadsby PJ; Ferrari MD; Csanyi A; Olesen J; Mills JG;
Cephalalgia; 2009 Jul; 29(7):742-50. PubMed ID: 19222510
[TBL] [Abstract][Full Text] [Related]
5. Nitroglycerin provocation in normal subjects is not a useful human migraine model?
Tvedskov JF; Iversen HK; Olesen J; Tfelt-Hansen P
Cephalalgia; 2010 Aug; 30(8):928-32. PubMed ID: 19740120
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
7. Prednisolone reduces nitric oxide-induced migraine.
Tfelt-Hansen P; Daugaard D; Lassen LH; Iversen HK; Olesen J
Eur J Neurol; 2009 Oct; 16(10):1106-11. PubMed ID: 19614965
[TBL] [Abstract][Full Text] [Related]
8. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study.
Dahlöf CG; Hauge AW; Olesen J
Cephalalgia; 2009 Nov; 29 Suppl 2():7-16. PubMed ID: 19723121
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S
Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
[TBL] [Abstract][Full Text] [Related]
13. Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine.
Silberstein SD; Schoenen J; Göbel H; Diener HC; Elkind AH; Klapper JA; Howard RA
Cephalalgia; 2009 Nov; 29 Suppl 2():17-27. PubMed ID: 19723122
[TBL] [Abstract][Full Text] [Related]
14. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department.
Cete Y; Dora B; Ertan C; Ozdemir C; Oktay C
Cephalalgia; 2005 Mar; 25(3):199-204. PubMed ID: 15689195
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
16. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
17. Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study.
Schoonman GG; van der Grond J; Kortmann C; van der Geest RJ; Terwindt GM; Ferrari MD
Brain; 2008 Aug; 131(Pt 8):2192-200. PubMed ID: 18502781
[TBL] [Abstract][Full Text] [Related]
18. Valdecoxib for treatment of a single, acute, moderate to severe migraine headache.
Kudrow D; Thomas HM; Ruoff G; Ishkanian G; Sands G; Le VH; Brown MT
Headache; 2005 Oct; 45(9):1151-62. PubMed ID: 16178945
[TBL] [Abstract][Full Text] [Related]
19. Coexisting typical migraine in familial hemiplegic migraine.
Hansen JM; Thomsen LL; Olesen J; Ashina M
Neurology; 2010 Feb; 74(7):594-600. PubMed ID: 20157162
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Diener HC
Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
